Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Cell Biol Int ; 36(1): 99-103, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21913891

RESUMEN

The morphological and functional heterogeneity of solid tumour cells can be observed in cancer cell lines cultured in vitro. We have combined analyses of microclones developed from single cells with micropore transmigration assays to demonstrate the co-existence of cellular subsets differing in morphology and motile activity, as well as Cx43 (connexin 43) and N-cadherin expression within lung carcinoma A549 populations. 'Fibroblastoid' cells, characterized by high motility, polarized morphology and plasmalemmal localization of Cx43, displayed the strongest aptitude for transmigration through narrow obstacles. Due to high mitotic activity, they maintain the whole population but can also give rise to a sub-population of quiescent and immobile 'epithelioid' cells. Our observations indicate that phenotypic transitions between the fibroblastoid and epithelioid phenotype account for the heterogeneity of metastable A549 cell populations.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/patología , Células Epiteliales/citología , Fibroblastos/citología , Neoplasias Pulmonares/patología , Cadherinas/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Línea Celular Tumoral , Movimiento Celular , Conexina 43/análisis , Conexina 43/metabolismo , Células Epiteliales/metabolismo , Fibroblastos/metabolismo , Humanos , Neoplasias Pulmonares/metabolismo , Mitosis , Fenotipo
2.
Cell Mol Biol Lett ; 16(4): 625-37, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21910090

RESUMEN

The formation of aqueous intercellular channels mediating gap junctional intercellular coupling (GJIC) is a canonical function of connexins (Cx). In contrast, mechanisms of GJIC-independent involvement of connexins in cancer formation and metastasis remain a matter of debate. Because of the role of Cx43 in the determination of carcinoma cell invasive potential, we addressed the problem of the possible Cx43 involvement in early prostate cancer invasion. For this purpose, we analysed Cx43-positive DU-145 cell subsets established from the progenies of the cells most readily transmigrating microporous membranes. These progenies displayed motile activity similar to the control DU-145 cells but were characterized by elevated Cx43 expression levels and GJIC intensity. Thus, apparent links exist between Cx43 expression and transmigration potential of DU-145 cells. Moreover, Cx43 expression profiles in the analysed DU-145 subsets were not affected by intercellular contacts and chemical inhibition of GJIC during the transmigration. Our observations indicate that neither cell motility nor GJIC determines the transmigration efficiency of DU-145 cells. However, we postulate that selective transmigration of prostate cancer cells expressing elevated levels of Cx43 expression may be crucial for the "leading front" formation during cancer invasion.


Asunto(s)
Conexina 43/metabolismo , Uniones Comunicantes/metabolismo , Próstata/metabolismo , Neoplasias de la Próstata , Migración Transendotelial y Transepitelial , Comunicación Celular , Línea Celular Tumoral , Movimiento Celular , Conexina 43/antagonistas & inhibidores , Conexina 43/genética , Uniones Comunicantes/genética , Uniones Comunicantes/patología , Expresión Génica/efectos de los fármacos , Silenciador del Gen/efectos de los fármacos , Ácido Glicirretínico/farmacología , Humanos , Masculino , Membranas Artificiales , Invasividad Neoplásica , Porosidad , Próstata/efectos de los fármacos , Próstata/patología , Neoplasias de la Próstata/genética , Neoplasias de la Próstata/metabolismo , Neoplasias de la Próstata/patología , ARN Interferente Pequeño/farmacología
3.
Clin Exp Metastasis ; 25(1): 53-64, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-17952617

RESUMEN

The integrin alpha(v)beta(3) is involved in multiple aspects of malignant cancer, including tumor angiogenesis and metastasis, which makes the receptor a key target for the development of anti-cancer therapies. We report here on the production, the characterization and the in vivo anti-angiogenic and anti-metastatic properties of a novel alpha(v)beta(3)-binding disintegrin, DisBa-01, isolated from a cDNA library made with RNAs from the venom gland of Bothrops alternatus. The 11,637 Da-recombinant monomeric form of DisBa-01 displayed an RGD motif and interacted with purified alpha(v)beta(3) integrin in surface plasmon resonance studies, in a dose-dependent and cation sensitive manner. A three-dimensional molecular model of DisBa-01 in complex with alpha(v)beta(3) predicted a large surface of contacts with the beta(3) subunit. DisBa-01 inhibited the adhesion of alpha(v)beta(3)-expressing human microvascular endothelial cell line-1 (HMEC-1) and murine melanoma cell line B16F10 to vitronectin (IC(50) = 555 nM and 225 nM, respectively), and transiently inhibited their proliferation without direct cell toxicity, but did not affect the binding nor the proliferation of a human breast cancer-derived cell line (MDA-MB-231) not expressing alpha(v)beta(3). In vivo, DisBa-01 dose-dependently decreased bFGF-induced angiogenesis in a matrigel plug assay in athymic nude mice (IC(50) = 83 nM). When injected intravenously to C57BL/6 mice together with B16F10 melanoma cells, DisBa-01 time- and dose-dependently inhibited lung metastasis monitored by bioluminescent imaging. We conclude that DisBa-01 is a potent new inhibitor of alpha(v)beta(3)-dependent adherence mechanisms involved in neo-vascularization and tumor metastasis processes.


Asunto(s)
Venenos de Crotálidos/farmacología , Desintegrinas/farmacología , Integrina alfaVbeta3/antagonistas & inhibidores , Melanoma Experimental/tratamiento farmacológico , Metástasis de la Neoplasia/tratamiento farmacológico , Neovascularización Patológica/tratamiento farmacológico , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Animales , Antineoplásicos/química , Antineoplásicos/farmacología , Secuencia de Bases , Bothrops , Adhesión Celular/efectos de los fármacos , Clonación Molecular , Venenos de Crotálidos/química , Desintegrinas/química , Desintegrinas/genética , Factores de Crecimiento de Fibroblastos/metabolismo , Humanos , Integrina alfaVbeta3/efectos de los fármacos , Ratones , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Conformación Proteica , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacología
4.
Front Biosci ; 13: 6604-16, 2008 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-18508682

RESUMEN

A monomeric RGD-disintegrin was recently identified from a cDNA library from the venom gland of Bothrops alternatus. The corresponding 12 kDa-recombinant protein, DisBa-01, specifically interacted with alpha(v)beta3 integrin and displayed potent anti-metastatic and anti-angiogenic properties. Here, the interaction of DisBa-01 with platelet alphaIIb beta3 integrin and its effects on hemostasis and thrombosis were investigated. DisBa-01 bound to Chinese Hamster Ovary (CHO) cells expressing beta3 or alphaIIb beta3 and promoted their adhesion and the adhesion of resting platelets onto glass coverslips. The disintegrin inhibited the binding of FITC-fibrinogen and FITC-PAC-1 to ADP-stimulated platelets and inhibited ADP-, TRAP- and collagen-induced aggregation of murine, rabbit or human platelets. In a flow chamber assay, DisBa-01 inhibited and reverted platelet adhesion to immobilized fibrinogen. DisBa-01 inhibited the phosphorylation of FAK following platelet activation. The intravenous injection of DisBa-01 in C57Bl6/j mice, prolonged tail bleeding time as well as thrombotic occlusion time in mesenteric venules and arterioles following vessel injury with FeCl3. In conclusion, DisBa-01 antagonizes the platelet alphaIIb beta3 integrin and potently inhibits thrombosis.


Asunto(s)
Venenos de Crotálidos/toxicidad , Hemostasis/efectos de los fármacos , Hemostáticos/farmacología , Animales , Bothrops , Células CHO/efectos de los fármacos , Cricetinae , Cricetulus , Quinasa 1 de Adhesión Focal/efectos de los fármacos , Quinasa 1 de Adhesión Focal/metabolismo , Humanos , Fosforilación , Adhesividad Plaquetaria/efectos de los fármacos , Agregación Plaquetaria/efectos de los fármacos , Proteínas Recombinantes/toxicidad , Transfección
5.
Int J Oncol ; 33(2): 309-15, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18636151

RESUMEN

Connexins and gap junctions play a crucial role during carcinogenesis. While diverse regulatory systems have been shown to modulate their function, the influence of cell motility on the intensity of gap junctional intercellular coupling has yet to be systematically addressed. Since cancer cell motility and intercellular coupling determine cancer development, we aimed at elucidating how mutual cell translocation modulates the intensity of gap junctional coupling in cell populations. Time-lapse analyses of the motility of connexin43 (Cx43)-coupled rat prostate carcinoma (MAT-LyLu) and mouse melanoma (B16) cells cultured on hyper-adhesive substrata revealed a reduced intensity of intercellular translocations in the two cell populations compared to the control conditions. While no detectable effects on the architecture of the actin cytoskeleton and Cx43 expression and phosphorylation were observed, the inhibition of cell motility was paralleled by an increase in the abundance of Cx43-positive plaques in cell-to-cell contacts and an enhancement of gap junctional coupling in cell populations cultured on hyper-adhesive substrata. Thus, a direct correlation between two cellular parameters crucial for carcinogenesis, i.e. cell motility and gap junctional coupling intensity exists in cancer cell populations.


Asunto(s)
Comunicación Celular/fisiología , Movimiento Celular/fisiología , Uniones Comunicantes/fisiología , Melanoma Experimental/patología , Neoplasias de la Próstata/patología , Animales , Línea Celular Tumoral , Conexina 43/metabolismo , Immunoblotting , Masculino , Melanoma Experimental/metabolismo , Ratones , Microscopía Fluorescente , Neoplasias de la Próstata/metabolismo , Ratas
6.
Eur J Cell Biol ; 88(12): 743-52, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19782426

RESUMEN

In some types of cancers, tumour-infiltrating monocytes/macrophages (TIM) may be responsible for the formation of an invasive microenvironment in a manner dependent on the secretion of soluble mediators such as tumour necrosis factor-alpha (TNF). Human pancreatic carcinoma (HPC-4) cells are able to induce TNF production by monocytes. Here, the effect of human peripheral blood monocytes, precursors of TIM, on the motility of co-cultured HPC-4 cells, was directly analysed in vitro. A phenotypic transition, i.e., the appearance of rear-front polarised HPC-4 cells paralleled by their increased motility, and increased motility of monocytes, were observed. This effect was attenuated when HPC-4 cells and monocytes were co-cultured in the presence of inhibitors of TNF production and anti-TNF monoclonal antibodies, indicating the specific role of this cytokine in determining paracrine loops between monocytes and cancer cells. Moreover, exogenous TNF induced HPC-4 cell motility concomitantly to the appearance of cellular features characteristic for epithelial-mesenchymal transition (EMT) such as rear-front polarisation, rearrangements of the actin cytoskeleton characteristic for motile cells and the induction of Snail-1 expression. Since cell movement is crucial for cancer invasion and the formation of metastases, these findings demonstrate an EMT-dependent mechanism of cancer progression which acts through the phenotypic transition of pancreatic cancer cells dependent on monocyte-derived TNF.


Asunto(s)
Comunicación Celular/fisiología , Movimiento Celular/fisiología , Leucocitos Mononucleares/patología , Neoplasias Pancreáticas/patología , Factor de Necrosis Tumoral alfa/biosíntesis , Diferenciación Celular/fisiología , Línea Celular Tumoral , Células Cultivadas , Técnicas de Cocultivo , Humanos , Leucocitos Mononucleares/metabolismo , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/farmacología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda